CYTOKINETICS INC (CYTK) Stock Balance Sheet
NASDAQ:CYTK - Nasdaq - US23282W6057 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 1.01B | 614.82M | 65.60M | 112.70M | 83.00M | |||
| Marketable Securities | 964.80M | 501.80M | 717.00M | 359.00M | 381.10M | |||
| Receivables | 244.00K | 1.28M | 100.00K | 51.80M | 4.40M | |||
| Other Current Assets | 13.57M | 25.17M | 12.50M | 12.20M | 5.70M | |||
| Total Current Assets | 1.02B | 628.05M | 795.20M | 535.70M | 474.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 140.57M | 147.74M | 163.20M | 146.40M | 22.60M | |||
| Investments And Advances | 269.17M | 40.53M | 46.70M | 152.10M | 37.00M | |||
| Other Non-Current Assets | 7.72M | 8.00M | 9.70M | 7.20M | N/A | |||
| Total Non-Current Assets | 417.46M | 196.26M | 219.60M | 305.60M | 59.60M | |||
| TOTAL ASSETS | 1.44B | 824.32M | 1.01B | 841.30M | 533.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 11.52M | 11.08M | 1.00M | 500.00K | N/A | |||
| Accrued Expenses | 68.68M | 60.53M | 56.90M | 49.20M | 22.10M | |||
| Accounts Payable | 72.99M | 85.66M | 25.60M | 21.10M | 8.10M | |||
| Other Current Liabilities | 18.03M | 9.56M | 1.10M | 1.00M | 1.00M | |||
| Total Current Liabilities | 109.81M | 102.68M | 84.60M | 71.90M | 31.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 644.50M | 607.56M | 610.60M | 143.60M | 135.70M | |||
| Other Non-Current Liabilities | 695.66M | 500.40M | 427.40M | 382.00M | 253.50M | |||
| Total Non-Current Liabilities | 1.34B | 1.11B | 1.04B | 525.60M | 389.20M | |||
| TOTAL LIABILITIES | 1.45B | 1.21B | 1.12B | 597.50M | 420.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -2.55B | -2.11B | -1.59B | -1.21B | -992.30M | |||
| Additional Paid In Capital | 2.53B | 1.73B | 1.48B | 1.45B | 1.11B | |||
| Common Shares | 118.00K | 102.00K | 100.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | 5.39M | -10.00K | -3.60M | -900.00K | 100.00K | |||
| Shares Outstanding | 117.89M | 101.64M | 94.80M | 84.80M | 71.00M | |||
| Tangible Book Value per Share | -0.12 | -3.80 | -1.14 | 2.88 | 1.60 | |||
| Total Shareholders' Equity | -13.91M | -386.32M | -107.90M | 243.90M | 113.40M | |||
| TOTAL LIABILITIES AND EQUITY | 1.44B | 824.32M | 1.01B | 841.30M | 533.80M | |||
| Statistics | ||||||||
| Debt/Equity | -46.33 | -1.57 | -5.66 | 0.59 | 1.20 | |||
| Current Ratio | 9.28 | 6.12 | 9.40 | 7.45 | 15.20 | |||
| Return On Assets (ROA) | -40.14% | -63.84% | -38.33% | -25.59% | -23.85% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | -88.27% | -112.26% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21